Drreddys Laboratories reported $5.98B in Loan Capital for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Ani Pharmaceuticals ANIP:US $ 286.31M 213K
Aurora Cannabis Inc ACB:CN 343.55M 26.3M
Bayer BAYN:GR € 36648M 167M
Canopy Growth Corp WEED:CN C$ 1.49B 107.27M
Catalent CTLT:US $ 4157M 34M
Corcept Therapeutics CORT:US $ 0M 0M
Endo International Ordinary Shares ENDP:US $ 8057.5M 9.85M
GlaxoSmithKline GSK:LN 29226M 8654M
Hikma Pharmaceutical HIK:LN 725M 26M
Horizon Pharma HZNP:US $ 2552.74M 2.49M
JAZZ PHA JAZZ:US $ 5992.87M 32.34M
Lannett LCI:US $ 610.08M 6.6M
Lonza Group LONN:SW 2.23B 555M
Novartis NOVN:VX SF 24373M 150M
Pacira Pharmaceuticals PCRX:US $ 729.74M 55.21M
Phibro Animal Health PAHC:US $ 400.62M 13.3M
Prestige Brands PBH:US $ 1481.16M 53.96M
Richter Gedeon RICHT:HB 12.19B 531M
Supernus Pharmaceuticals SUPN:US $ 400.38M 21.13M
Teva Pharmaceutical TEVA:IT 20.84B 777M